Epidemiology of invasive fungal infections in lung transplant recipients in Western Australia.

Andrew ChangMichael MuskMelanie LavenderJeremy WrobelMeow-Chong YawSharon LawrenceShiji ChirayathPeter A Boan

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2019)

In our cohort the rate of IFI was comparatively low, likely because of comprehensive early antifungal use and preemptive therapy at any time after transplant. Prospective studies of fungal colonization late after LT are required to determine the risks and benefits of watchful waiting compared to preemptive therapy.

Keyphrases

risk factors
stem cells
human health
risk assessment
bone marrow
cell therapy
smoking cessation
replacement therapy